Serial Number
88983895
Owner
ILLUMINA, INC.Attorney
Susan M. NatlandFirst Use Date
May 14, 2020
Filing Date
Apr 24, 2020
COVIDSEQ Trademark
Serial Number: 88983895 • Registration: 6885352
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Susan M. Natland Baker & Hostetler LLP
600 Anton Blvd, Suite 900
Costa Mesa, CA 92626-7221
United States
Trademark Details
Filing Date
April 24, 2020
Registration Date
October 25, 2022
First Use Anywhere
May 14, 2020
First Use in Commerce
June 9, 2020
Published for Opposition
June 8, 2021
Goods & Services
Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19
Diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use; Diagnostic reagents and preparations for medical use; Kits comprised principally of diagnostic reagents with a protocol for use thereof for medical purposes; Kits comprised of diagnostic nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, biological preparations for medical genetic testing and medical diagnostic purposes; diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use in the fields of medical diagnostics, clinical diagnostics, medical forensics, laboratory medicine, genetic testing, and genetics; all of the foregoing for the detection of or in the field of COVID-19